Search results
Author(s):
Devi Nair
,
Nassir F Marrouche
,
Janet Han
Added:
1 year ago
In this episode of Rhythm Interventions Unplugged, host Dr Devi Nair sits down with leading electrophysiologists Dr Nassir Marrouche and Dr Janet Han to explore the future of electrophysiology (EP) training in the digital age. With virtual learning, AI in cardiology, and cutting-edge EP technology transforming education, how are training programs evolving to keep up?From bite-sized digital…
View more
Added:
1 day ago
Source:
Radcliffe CVRM
Renin-independent aldosteronism is a common and often underrecognised condition. A new analysis from the Atherosclerosis Risk in Communities (ARIC) study has investigated whether this broader spectrum of aldosteronism is associated with incident cardiovascular disease (CVD) in older, community-dwelling adults.¹MethodologyThis prospective cohort analysis included 3,477 participants from the ARIC…
View more
Navigating Digital Medical Education
Author(s):
Gurleen Kaur
,
Saman Nematollahi
,
Thomas Das
,
et al
Added:
1 year ago
Expert Opinion
Author(s):
Patrick W Serruys
Added:
1 year ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary…
View more
Author(s):
Brian Bergmark
Added:
1 year ago
ACC.24 — Dr Brian Bergmark (Brigham and Women's Hospital, Harvard Medical School, US) joins us in this interview to discuss the findings of a study into olezarsen, previously known as AKCEA-APOCIII-LRx, in patients with hypertriglyceridemia and atherosclerotic cardiovascular disease (ASCVD), with or without severe hypertriglyceridemia (NCT05355402).This multicenter, randomized, double-blind study…
View more
Ep 5: The Future of EP Training: Digital, AI & Hands-On Learning
Added:
1 year ago
Podcast Episode
Sukriti Banthiya
Research Area(s) / Expertise:
Job title: Fellow physician
Author
Added:
3 days ago
Source:
Radcliffe CVRM
A new study has found that the novel oral GLP-1 receptor agonist, orforglipron, demonstrated superior glycaemic control compared to oral semaglutide in adults with type 2 diabetes (T2D). The findings come from the ACHIEVE-3 trial, a phase 3 study published in The Lancet.¹Mechanism of ActionOrforglipron is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist designed for once-daily oral…
View more
New Innovations to Address Sudden Cardiac Arrest
Author(s):
Christine Shen
,
Sanjeev P Bhavnani
,
John D Rogers
Added:
1 year ago
Review Article